Extrait

To evaluate the incidence of patients with bradycardia (heart rate < 45 beats per min) and bradyarrhythmic ECG events during 6-hour monitoring period as measured by heart rate and second and third-degree AV blocks after treatment initiation of fingolimod 0.5 mg.

Critère d'inclusion

• Conduction abnormalities in patients with relapsing-remitting multiple sclerosis

Liens

• ictrp
• euctr